Chronic Disease  >>  MK-0359  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK-0359 / Merck (MSD)
NCT00482235: A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)

Completed
2
45
US
MK0359
Merck Sharp & Dohme LLC
Pulmonary Disease, Chronic Obstructive
04/03
04/03

Download Options